BMO Capital Upgrades Edwards Lifesciences To Outperform

BMO Capital upgraded

from Market Perform to Outperform. Edwards Lifesciences shares have gained 64.68 percent over the past 52 weeks, while the S&P 500 index has surged 6.59 percent in the same period. Edwards Lifesciences' shares rose 0.01 percent to close at $132.91 yesterday.